Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Overall Survival In Early Stage Chronic Lymphocytic Leukemia Patients With Treatment Indication Due To Disease Progression: Follow-Up Data Of The CLL1 Trial Of The German CLL Study Group (GCLLSG)

Manuela A. Bergmann, MD, Raymonde Busch, PhD, Barbara Eichhorst, MD, Andreas Buehler, MD, Norbert Fischer, MD, Michael J Eckart, MD, Ursula Vehling-Kaiser, MD, Ulrich Jäger, MD, Georg Hopfinger, MD, Clemens Wendtner, MD, Kirsten Fischer, MD, Bertold Emmerich, MD, Hartmut Döhner, MD, Michael Hallek, M.D. Ph.D., Stephan Stilgenbauer, MD

Blood (2013) 122 (21): 4127.

https://doi.org/10.1182/blood.V122.21.4127.4127

Published: 2013

Journal Articles

Testing G-CSF responsiveness predicts the individual susceptibility to infection and consecutive treatment in recipients of high-dose chemotherapy

Blood (2011) 117 (7): 2121–2128.

https://doi.org/10.1182/blood-2010-06-290080

Published: 2011

Journal Articles

Early Autologous Stem Cell Transplantation (autoSCT) May Overcome the Adverse Impact of Del 11q- in Poor-Risk Chronic Lymphocytic Leukemia (CLL): Results From the GCLLSG CLL3 Trial.

Peter Dreger, Hartmut Döhner, Hildegard Greinix, MD, Fabienne McClanahan, MD, Manfred Hensel, Bernd Hertenstein, Ulrich Dührsen, MD, PhD, Markus Hentrich, Lorenz Trümper, Ruth Sonnen, Bertold Emmerich, Wolfgang Ulrich Knauf, Georg Hopfinger, MD, Michael Hallek, Michael Kneba, MD, PhD, Norbert Schmitz, Stephan Stilgenbauer, MD

Blood (2009) 114 (22): 879.

https://doi.org/10.1182/blood.V114.22.879.879

Published: 2009

Journal Articles

Results of First-in-Man Phage Idiotype Vaccine Study in Patients with Multiple Myeloma.

Tim Roehnisch, Wolfgang Nagel, Thomas Boehm, Mariel Donceau, Carole Bourquin, Dilda A. Roehnisch, Beata Rutz, Christian Straka, Bertold Emmerich, Fuat S. Oduncu

Blood (2009) 114 (22): 1858.

https://doi.org/10.1182/blood.V114.22.1858.1858

Published: 2009

Journal Articles

First-line therapy with fludarabine compared with chlorambucil does not result in a major benefit for elderly patients with advanced chronic lymphocytic leukemia

Blood (2009) 114 (16): 3382–3391.

https://doi.org/10.1182/blood-2009-02-206185

Published: 2009

Includes: Supplemental data

Journal Articles

The Effects of Induction Chemotherapy and High-Dose Melphalan with Tandem Autologous Transplantation in Multiple Myeloma: The Prospective Randomized DSMM 2 Study.

Blood (2007) 110 (11): 446.

https://doi.org/10.1182/blood.V110.11.446.446

Published: 2007

Journal Articles

Myeloma Cell Proliferation Is Inhibitied by the Activation of Adenosine Monophosphate Activated Protein Kinase (AMPK).

Philipp Baumann, Sonja Mandl-Weber, Bertold Emmerich, Christian Straka, Daniel Franke, Ralf Schmidmaier

Blood (2006) 108 (11): 5045.

https://doi.org/10.1182/blood.V108.11.5045.5045

Published: 2006

Journal Articles

Fludarabine plus cyclophosphamide versus fludarabine alone in first-line therapy of younger patients with chronic lymphocytic leukemia

Barbara F. Eichhorst, Raymonde Busch, Georg Hopfinger, Rita Pasold, Manfred Hensel, Cordelia Steinbrecher, Siegfried Siehl, Ulrich Jäger, Manuela Bergmann, Stephan Stilgenbauer, Carmen Schweighofer, Clemens M. Wendtner, Hartmut Döhner, Günter Brittinger, Bertold Emmerich, Michael Hallek, the German CLL Study Group

Blood (2006) 107 (3): 885–891.

https://doi.org/10.1182/blood-2005-06-2395

Published: 2006

Journal Articles

17p Deletion Predicts for Inferior Overall Survival after Fludarabine - Based First Line Therapy in Chronic Lymphocytic Leukemia: First Analysis of Genetics in the CLL4 Trial of the GCLLSG.

Stephan Stilgenbauer, MD, Alexander Kröber, MD, Raymonde Busch, PhD, Barabara Eichhorst, MD, Dirk Kienle, MD, Dirk Winkler, MD, Georg Hopfinger, MD, Peter Lichter, MD, Bertold Emmerich, MD, Michael Hallek, MD, Hartmut Döhner, MD, The GCLLSG

Blood (2005) 106 (11): 715.

https://doi.org/10.1182/blood.V106.11.715.715

Published: 2005

Journal Articles

Combination Treatment with Imatinib and Mitoxantrone/Etoposide Is a Suitable Preparative Regimen before Allogeneic Transplantation in Patients with Myeloid Blast Crisis of Chronic Myeloid Leukemia.

Stefan Fruehauf, MD, Julian Topaly, MD, Eike C. Buss, MD, Tanja Lahaye, MD, Oliver G. Ottmann, MD, Thomas Fischer, MD, Bertold Emmerich, MD, Ulrike Haus, Rudiger Hehlmann, MD, Anthony D. Ho, MD, Andreas Hochhaus, MD

Blood (2005) 106 (11): 1105.

https://doi.org/10.1182/blood.V106.11.1105.1105

Published: 2005

Journal Articles

Higher Expression Levels of the Adhesion Molecules VLA-4 and ICAM-1 on Multiple Myeloma Cells after Chemotherapy Are Associated with Survival of a Multidrug Resistant Subpopulation in Vivo.

Ralf Schmidmaier, MD, Kerstin Mörsdorf, Philipp Baumann, Bertold Emmerich, MD, Gerold Meinhardt, MD

Blood (2004) 104 (11): 4866.

https://doi.org/10.1182/blood.V104.11.4866.4866

Published: 2004

Journal Articles

A Multicenter Phase I/II Trial of the Combination of Imatinib Mesylate with Mitoxantrone/Etoposide and Cytarabine in Patients with CML in Myeloid Blast Crisis: A Trend to a Longer Survival in Patients Receiving More Aggressive Treatment Schedules.

Stefan Fruehauf, MD, Julian Topaly, MD, Eike C. Buss, MD, Thomas Fischer, MD, Bertold Emmerich, MD, Harald Gschaidmeier, MD, Rudiger Hehlmann, MD, Andreas Hochhaus, MD

Blood (2004) 104 (11): 2929.

https://doi.org/10.1182/blood.V104.11.2929.2929

Published: 2004

Journal Articles

Early Autologous Stem Cell Transplantation (SCT) in Genetically Poor-Risk Chronic Lymphocytic Leukemia Is Feasible and Effective: Results from a Prospective Multicenter Study (GCLLSG CLL3 Protocol).

Peter Dreger, Raimonde Busch, Stephan Stilgenbauer, Hildegard Greinix, Manfred Hensel, Bernd Hertenstein, Ulrich Duehrsen, Marcus Hentrich, Lorenz H. Truemper, Norbert Schmitz, Matthias Ritgen, Bertold Emmerich, Michael J. Hallek, Michael Kneba, Hartmut Dohner

Blood (2004) 104 (11): 146.

https://doi.org/10.1182/blood.V104.11.146.146

Published: 2004

Journal Articles

Responsiveness to G-CSF before leukopenia predicts defense to infection in high-dose chemotherapy recipients

Christian Straka, Fuat Oduncu, Axel Hinke, Hermann Einsele, Evi Drexler, Brigitte Schnabel, Lubomir Arseniev, Jochem Walther, August König, Bertold Emmerich

Blood (2004) 104 (7): 1989–1994.

https://doi.org/10.1182/blood-2004-02-0628

Published: 2004

Journal Articles

The HMG-CoA reductase inhibitor simvastatin overcomes cell adhesion–mediated drug resistance in multiple myeloma by geranylgeranylation of Rho protein and activation of Rho kinase

Ralf Schmidmaier, Philipp Baumann, Meral Simsek, Farshid Dayyani, Bertold Emmerich, Gerold Meinhardt

Blood (2004) 104 (6): 1825–1832.

https://doi.org/10.1182/blood-2003-12-4218

Published: 2004

Journal Articles

Generalized crystal-storing histiocytosis associated with monoclonal gammopathy: molecular analysis of a disorder with rapid clinical course and review of the literature

Annette Lebeau, Evelyn Zeindl-Eberhart, Eva-Christina Müller, Josef Müller-Höcker, Peter Roman Jungblut, Bertold Emmerich, Udo Löhrs

Blood (2002) 100 (5): 1817–1827.

https://doi.org/10.1182/blood.V100.5.1817.h81702001817_1817_1827

Published: 2002

Journal Articles

Rituximab therapy of patients with B-cell chronic lymphocytic leukemia

Dieter Huhn, Christoph von Schilling, Martin Wilhelm, Anthony D. Ho, Michael Hallek, Rolf Kuse, Wolfgang Knauf, Ute Riedel, Axel Hinke, Stefanie Srock, Stefan Serke, Christian Peschel, Bertold Emmerich

Blood (2001) 98 (5): 1326–1331.

https://doi.org/10.1182/blood.V98.5.1326

Published: 2001

Journal Articles

CD40-Activated B-Cell Chronic Lymphocytic Leukemia Cells for Tumor Immunotherapy: Stimulation of Allogeneic Versus Autologous T Cells Generates Different Types of Effector Cells

Raymund Buhmann, Annette Nolte, Doreen Westhaus, Bertold Emmerich, Michael Hallek

Blood (1999) 93 (6): 1992–2002.

https://doi.org/10.1182/blood.V93.6.1992.406k23_1992_2002

Published: 1999

Journal Articles

Elevated Serum Thymidine Kinase Levels Identify a Subgroup at High Risk of Disease Progression in Early, Nonsmoldering Chronic Lymphocytic Leukemia

Michael Hallek, Irmgard Langenmayer, Christoph Nerl, Wolfgang Knauf, Hermann Dietzfelbinger, Dagmar Adorf, Marianne Ostwald, Raymonde Busch, Ingrid Kuhn-Hallek, Eckhard Thiel, Bertold Emmerich

Blood (1999) 93 (5): 1732–1737.

https://doi.org/10.1182/blood.V93.5.1732

Published: 1999

NARROW

Overall Survival In Early Stage Chronic Lymphocytic Leukemia Patients With Treatment Indication Due To Disease Progression: Follow-Up Data Of The CLL1 Trial Of The German CLL Study Group (GCLLSG)

Testing G-CSF responsiveness predicts the individual susceptibility to infection and consecutive treatment in recipients of high-dose chemotherapy

Early Autologous Stem Cell Transplantation (autoSCT) May Overcome the Adverse Impact of Del 11q- in Poor-Risk Chronic Lymphocytic Leukemia (CLL): Results From the GCLLSG CLL3 Trial.

Results of First-in-Man Phage Idiotype Vaccine Study in Patients with Multiple Myeloma.

First-line therapy with fludarabine compared with chlorambucil does not result in a major benefit for elderly patients with advanced chronic lymphocytic leukemia

The Effects of Induction Chemotherapy and High-Dose Melphalan with Tandem Autologous Transplantation in Multiple Myeloma: The Prospective Randomized DSMM 2 Study.

Myeloma Cell Proliferation Is Inhibitied by the Activation of Adenosine Monophosphate Activated Protein Kinase (AMPK).

Fludarabine plus cyclophosphamide versus fludarabine alone in first-line therapy of younger patients with chronic lymphocytic leukemia

17p Deletion Predicts for Inferior Overall Survival after Fludarabine - Based First Line Therapy in Chronic Lymphocytic Leukemia: First Analysis of Genetics in the CLL4 Trial of the GCLLSG.

Combination Treatment with Imatinib and Mitoxantrone/Etoposide Is a Suitable Preparative Regimen before Allogeneic Transplantation in Patients with Myeloid Blast Crisis of Chronic Myeloid Leukemia.

Higher Expression Levels of the Adhesion Molecules VLA-4 and ICAM-1 on Multiple Myeloma Cells after Chemotherapy Are Associated with Survival of a Multidrug Resistant Subpopulation in Vivo.

A Multicenter Phase I/II Trial of the Combination of Imatinib Mesylate with Mitoxantrone/Etoposide and Cytarabine in Patients with CML in Myeloid Blast Crisis: A Trend to a Longer Survival in Patients Receiving More Aggressive Treatment Schedules.

Early Autologous Stem Cell Transplantation (SCT) in Genetically Poor-Risk Chronic Lymphocytic Leukemia Is Feasible and Effective: Results from a Prospective Multicenter Study (GCLLSG CLL3 Protocol).

Responsiveness to G-CSF before leukopenia predicts defense to infection in high-dose chemotherapy recipients

The HMG-CoA reductase inhibitor simvastatin overcomes cell adhesion–mediated drug resistance in multiple myeloma by geranylgeranylation of Rho protein and activation of Rho kinase

Generalized crystal-storing histiocytosis associated with monoclonal gammopathy: molecular analysis of a disorder with rapid clinical course and review of the literature

Rituximab therapy of patients with B-cell chronic lymphocytic leukemia

CD40-Activated B-Cell Chronic Lymphocytic Leukemia Cells for Tumor Immunotherapy: Stimulation of Allogeneic Versus Autologous T Cells Generates Different Types of Effector Cells

Elevated Serum Thymidine Kinase Levels Identify a Subgroup at High Risk of Disease Progression in Early, Nonsmoldering Chronic Lymphocytic Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only